SAGE   $7.5600000000000005  4.85% Market Closed After Close 7.4 -2.12%

SAGE Therapeutics Inc
Total Cash 646.79M
totalCashPerShare 10.594
EBITDA -448.12M
Total Debt 1.41M
quickRatio 9.512
currentRatio 9.948
Total Revenue 97.24M
debtToEquity 0.225
Revenue/Share 1.617
ROA -0.31577
ROE -0.55279
grossProfits
freeCashflow -207.33M
operatingCashflow -373.65M
earningsGrowth
revenueGrowth 2.498
grossMargins -2.13591
ebitdaMargins 0.0
operatingMargins -12.8611
profitMargins 0.0
enterpriseValue -226.58M
forwardPE -1.3775101
floatShares 48.34M
sharesOutstanding 61.05M
sharesShort 5.71M
sharesShortPriorMonth 6.22M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.90%
Short Ratio help_outline 8.81%
shortPercentOfFloat 0.11%
impliedSharesOutstanding
bookValue 10.314
Price To Book help_outline 0.67
earningsQuarterlyGrowth
netIncomeToCommon -445.67M
trailingEps -7.41%
forwardEps -4.98%
enterpriseToEbitda 0.51
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.55 3Q 2024
institutionsCount 280
lastUpdated Oct. 16, 2024, 12:27 p.m.